The powerful applications of polyunsaturated fatty acids in improving the therapeutic efficacy of anticancer drugs

Expert Opinion on Drug Delivery

Volumn 9, Issue 1, 2012, Pages 1-7

  Wang, Jianhong ^a   Luo, Tianwei ^a   Li, Shaobin ^a   Zhao, Jin ^a  

^a HENAN UNIVERSITY   (China)

Author keywords

Drug delivery; Polyunsaturated fatty acids; Therapeutic efficacy; Tumor targeting

Indexed keywords

10 HYFROXYCAMPTOTHECIN; ANTINEOPLASTIC AGENT; ARACHIDONIC ACID; DOCOSAHEXAENOIC ACID; DOXORUBICIN; LINOLEIC ACID; LINOLENIC ACID; PACLITAXEL; POLYUNSATURATED FATTY ACID; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; AREA UNDER THE CURVE; CANCER INHIBITION; DRUG CONJUGATION; DRUG DISTRIBUTION; DRUG EFFICACY; DRUG PENETRATION; DRUG SOLUBILITY; DRUG STRUCTURE; HUMAN; MAXIMUM PLASMA CONCENTRATION; NONHUMAN; REVIEW; TUMOR GROWTH;

ANIMALS; ANTINEOPLASTIC AGENTS; DRUG CARRIERS; DRUG DESIGN; FATTY ACIDS, UNSATURATED; HUMANS; MOLECULAR STRUCTURE; NEOPLASMS;

EID: 84255167386     PISSN: 17425247     EISSN: 17447593     Source Type: Journal    
DOI: 10.1517/17425247.2011.618183     Document Type: Review

References (21)

1. Jaracz S, Chen J, Kuznetsova LV, et al. Recent advances in tumor-targeting anticancer drug conjugates. Bioorg Med Chem 2005;13:5043-54 (Pubitemid 41039965)
2. Leamon CP, Reddy JA. Folate-targeted chemotherapy. Adv Drug Deliv Rev 2004;56:1127-41 (Pubitemid 38496512)
3. Lu Y, Low PS. Folate-mediated delivery of macromolecular anticancer therapeutic agents. Adv Drug Deliv Rev 2002;54:675-93 (Pubitemid 35247522)
4. Chu TC, Marks JW III, Lavery LA, et al. Aptamer:toxin conjugates that specifically target prostate tumor cells. Cancer Res 2006;66:5989-92
5. Nagy A, Schally AV, Halmos G, et al. Synthesis and biological evaluation of cytotoxic analogs of somatostatin containing doxorubicin or its intensely potent derivative, 2-pyrrolinodoxorubicin. Proc Natl Acad Sci USA 1998;95:1794-9
6. Luo Y, Bernshaw NJ, Lu Z-R, et al. Targeted delivery of doxorubicin by HPMA copolymer-hyaluronan bioconjugates. Pharm Res 2002;19:396-402 (Pubitemid 34408935)
7. Monsigny M, Roche A-C, Midoux P, et al. Glycoconjugates as carriers for specific delivery of therapeutic drugs and genes. Adv Drug Deliv Rev 1994;14:1-24 (Pubitemid 24131671)
8. Ojima I. Guided molecular missiles for tumor-targeting chemotherapy-case studies using the second-generation taxoids as warheads. Acc Chem Res 2008;41:108-19
9. Sauer LA, Dauchy RT. The effect of omega-6 and omega-3 fatty acids on 3H-thymidine incorporation in hepatoma 7288CTC perfused in situ. Br J Cancer 1992;66:297-303
10. Sauer LA, Nagel WO, Dauchy RT, et al. Stimulation of tumor growth in adult rats in vivo during an acute fast. Cancer Res 1986;46:3469-75 (Pubitemid 16096893)
11. Sauer LA, Dauchy RT, Blask DE. Mechanism for the antitumor and anticachectic effects of n-3 fatty acids. Cancer Res 2000;60:5289-95
12. Grammatikos SI, Subbaiah PV, VictorTA, et al. n-3 and n-6 Fatty acid processing and growth effects in neoplastic and non-cancerous human mammary epithelial cell lines. Br J Cancer 1994;70:219-27 (Pubitemid 24247140)
13. Diomede L, Colotta F, Piovani B, et al. Induction of apoptosis in human leukemic cells by the ether lipid 1-octadecyl-2-methyl-racglycero-3- phosphocholine. A possible basis for its selective action. Int J Cancer Res 1993;53:124-30 (Pubitemid 23018434)
14. Wigmore SJ, Ross JA, Falconer JS, et al. The effect of polyunsaturated fatty acids on the progress of cachexia in patients with pancreatic cancer. Nutrition 1996;12:S27-30
15. Hawkins RA, Sangster K, Arends MJ. Apoptotic death of pancreatic cancer cells induced by polyunsaturated fatty acids varies with double bond number and involves an oxidative mechanism. J Pathol 1998;185:61-70 (Pubitemid 28266718)
16. Bradley MO, Webb NL, Anthony FH, et al. Tumor targeting by covalent conjugation of a natural fatty acid to taxol. Clin Cancer Res 2001;7:3229-38 (Pubitemid 32963848)
17. Kuznetsova LV, Chen J, Sun L, et al. Syntheses and evaluation of novel fatty acid-2ndgeneration taxoid conjugates as promising anticancer agents. Bioorg Med Chem Lett 2006;16:974-7 (Pubitemid 43059863)
18. Wang Y, Li L, Jiang W, et al. Synthesis and evaluation of a DHA and 10-hydroxycamptothecin conjugate. Bioorg Med Chem 2005;13:5592-9 (Pubitemid 41187922)
19. Wang Y, Li L, Jiang W, et al. Synthesis and preliminary antitumor activity evaluation of a DHA and doxorubicin conjugate. Bioorg Med Chem Lett 2006;16:2974-7
20. Kaneko T, Willner D, Monkovic I, et al. New hydrazone derivatives of adriamycin and their immunoconjugates-a correlation between acid stability and cytotoxicity. Bioconjug Chem 1991;2:133
21. Kratz F, Warnecke A, Scheuermann K, et al. Probing the cysteine-34 position of endogenous serum albumin with thiol-binding doxorubicin derivatives. Improved efficacy of an acid-sensitive doxorubicin derivative with specific albumin-binding properties compared to that of the parent compound. J Med Chem 2002;45:5523